Development of Novel Drug Delivery Systems for Improved Therapeutic Outcomes in Cancer Treatment

Thesis Abstract

Abstract
Cancer remains one of the leading causes of mortality worldwide, necessitating continuous advancements in treatment strategies. The development of novel drug delivery systems has emerged as a promising approach to enhance therapeutic outcomes in cancer treatment. This thesis focuses on exploring and evaluating innovative drug delivery systems tailored for improved efficacy and reduced side effects in cancer therapy. The introduction provides a comprehensive overview of the challenges associated with conventional cancer treatments and the rationale behind the development of novel drug delivery systems. The background of the study highlights the current landscape of cancer treatment and the critical need for targeted drug delivery approaches. The problem statement underscores the limitations of existing cancer treatments, including systemic toxicity and poor drug bioavailability, driving the urgency for more effective delivery systems. The objectives of the study aim to design and assess novel drug delivery systems that can enhance the therapeutic efficacy of anticancer agents while minimizing adverse effects. The study also delineates the scope of research, outlining the specific areas of focus and the methodology employed to achieve the stated objectives. The significance of the study lies in its potential to revolutionize cancer treatment by improving drug delivery efficiency and patient outcomes. The literature review delves into existing research on various drug delivery systems, including nanoparticles, liposomes, and micelles, highlighting their advantages and limitations in cancer therapy. The research methodology section describes the experimental design, materials, and methods used to develop and evaluate the novel drug delivery systems. The discussion of findings section presents the results of the experimental studies, including drug release profiles, cellular uptake mechanisms, and in vitro/in vivo anticancer efficacy assessments. The implications of these findings on the field of cancer treatment are thoroughly analyzed and discussed. In conclusion, this thesis underscores the importance of innovative drug delivery systems in advancing cancer therapy and improving patient outcomes. The novel drug delivery systems developed in this study hold great promise for enhancing the precision, efficacy, and safety of anticancer treatments. Overall, this research contributes valuable insights to the ongoing efforts to combat cancer and improve the quality of life for patients undergoing treatment.